Overview
Immunome is a targeted oncology company headquartered in Bothell, Washington. Its lead candidate, varegacestat, a gamma secretase inhibitor for desmoid tumors, is under FDA review with a PDUFA target action date of April 28, 2027, and its pipeline includes antibody-drug conjugates such as IM-1021. It has no approved products.
Hiring snapshot
Hiring by specialty
Top states
Open roles
Newest first, from Immunome’s careers page.
- Senior Oncology Account Manager (Washington DC)Field Based - Washington Dc10d ago$210k–$235k
- Senior Oncology Account Manager (Upstate NY)Field Based - Buffalo10d ago$210k–$235k
- Senior Oncology Account Manager (Tennessee)Field Based - Nashville10d ago$210k–$235k
- Senior Oncology Account Manager (Tampa)Field Based - Tampa10d ago$210k–$235k
- Senior Oncology Account Manager (Southern Texas)Field Based - San Antonio10d ago$210k–$235k
- Senior Oncology Account Manager (Seattle)Field Based - Seattle10d ago$210k–$235k
Divisions
Division information is pending company verification.Once Immunome claims its page, you will see each division, who it calls on and how it pays.
Claim your pageMore from Immunome
These sections fill in when Immunome claims and verifies its page.
Life at ImmunomePhotos, stories and culture. Not added yet.
BenefitsNot added yet.